Grantham, Mayo, Van Otterloo & Co (GMO)
PFE icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Pfizer PFE Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$64.2M Sell
2,285,443
-93,526
-4% -$2.49M 0.16% 58
2025
Q4 		$59.2M Sell
2,378,969
-42,293
-2% -$1.07M 0.15% 59
2025
Q3 		$61.7M Sell
2,421,262
-133,144
-5% -$3.29M 0.17% 52
2025
Q2 		$61.9M Sell
2,554,406
-325,720
-11% -$7.6M 0.19% 51
2025
Q1 		$73M Buy
2,880,126
+203,388
+8% +$5.32M 0.23% 45
2024
Q4 		$71M Buy
2,676,738
+464,885
+21% +$12.6M 0.23% 44
2024
Q3 		$64M Sell
2,211,853
-408,161
-16% -$11.9M 0.2% 54
2024
Q2 		$73.3M Buy
2,620,014
+174,969
+7% +$4.82M 0.25% 51
2024
Q1 		$67.8M Sell
2,445,045
-150,264
-6% -$4.17M 0.25% 54
2023
Q4 		$74.7M Buy
2,595,309
+321,372
+14% +$9.71M 0.33% 53
2023
Q3 		$75.4M Buy
2,273,937
+339,589
+18% +$12M 0.36% 53
2023
Q2 		$71M Buy
1,934,348
+479,118
+33% +$18.6M 0.33% 54
2023
Q1 		$59.4M Buy
1,455,230
+338,600
+30% +$14.6M 0.3% 59
2022
Q4 		$57.2M Buy
1,116,630
+306,770
+38% +$14.7M 0.3% 62
2022
Q3 		$35.4M Sell
809,860
-9,662
-1% -$470K 0.2% 94
2022
Q2 		$43M Buy
819,522
+636,200
+347% +$32.4M 0.23% 81
2022
Q1 		$9.49M Sell
183,322
-174,323
-49% -$9.04M 0.05% 271
2021
Q4 		$21.1M Sell
357,645
-457,535
-56% -$22.7M 0.1% 164
2021
Q3 		$35.1M Buy
815,180
+54,450
+7% +$2.41M 0.17% 94
2021
Q2 		$29.8M Buy
760,730
+381,545
+101% +$14.8M 0.15% 117
2021
Q1 		$13.7M Buy
379,185
+214,000
+130% +$7.6M 0.08% 193
2020
Q4 		$6.08M Sell
165,185
-30,527
-16% -$1.12M 0.04% 267
2020
Q3 		$6.82M Buy
195,712
+2,635
+1% +$92.4K 0.05% 198
2020
Q2 		$5.99M Sell
193,077
-100,486
-34% -$3.41M 0.04% 225
2020
Q1 		$9.09M Sell
293,563
-100,432
-25% -$3.42M 0.08% 148
2019
Q4 		$14.6M Sell
393,995
-175,006
-31% -$6.23M 0.1% 149
2019
Q3 		$19.4M Buy
569,001
+24,987
+5% +$909K 0.13% 115
2019
Q2 		$22.4M Buy
544,014
+5,581
+1% +$222K 0.16% 103
2019
Q1 		$21.7M Sell
538,433
-281,451
-34% -$11.3M 0.16% 98
2018
Q4 		$34M Sell
819,884
-265,875
-24% -$11M 0.27% 69
2018
Q3 		$45.4M Sell
1,085,759
-2,062,754
-66% -$79.4M 0.31% 65
2018
Q2 		$108M Sell
3,148,513
-1,364,834
-30% -$46.6M 0.77% 39
2018
Q1 		$152M Buy
4,513,347
+277,008
+7% +$9.52M 0.93% 33
2017
Q4 		$146M Sell
4,236,339
-128,061
-3% -$4.37M 0.86% 39
2017
Q3 		$148M Sell
4,364,400
-677,279
-13% -$21.8M 0.86% 34
2017
Q2 		$161M Sell
5,041,679
-2,964
-0.1% -$93.5K 0.89% 31
2017
Q1 		$164M Sell
5,044,643
-701,155
-12% -$22.1M 0.92% 29
2016
Q4 		$177M Sell
5,745,798
-1,333,728
-19% -$40.7M 0.95% 25
2016
Q3 		$227M Sell
7,079,526
-5,865,506
-45% -$196M 1.07% 18
2016
Q2 		$432M Buy
12,945,032
+6,830,917
+112% +$218M 1.77% 12
2016
Q1 		$172M Sell
6,114,115
-186,794
-3% -$5.34M 0.64% 38
2015
Q4 		$193M Sell
6,300,909
-332,536
-5% -$10.5M 0.69% 40
2015
Q3 		$198M Buy
6,633,445
+318,517
+5% +$10.2M 0.69% 32
2015
Q2 		$201M Buy
6,314,928
+6,280,046
+18,004% +$205M 0.65% 37
2015
Q1 		$1.15M Sell
34,882
-881
-2% -$28K ﹤0.01% 361
2014
Q4 		$1.06M Sell
35,763
-1,135,710
-97% -$32.6M ﹤0.01% 369
2014
Q3 		$32.9M Buy
1,171,473
+803,092
+218% +$22.5M 0.09% 116
2014
Q2 		$10.4M Sell
368,381
-6,737,476
-95% -$192M 0.03% 195
2014
Q1 		$217M Sell
7,105,857
-21,145,378
-75% -$630M 0.56% 37
2013
Q4 		$821M Sell
28,251,235
-22,052,086
-44% -$642M 1.99% 14
2013
Q3 		$1.37B Sell
50,303,321
-10,852,602
-18% -$295M 3.61% 10
2013
Q2 		$1.63B Buy
+61,155,923
New +$1.69B 4.23% 5

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s PFE Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) reduced its Pfizer (PFE) stake by 3.9% in Q1 2026, selling an estimated $2.49M and leaving 2,285,443 shares worth $64.2M. The position accounts for 0.16% of the portfolio, ranked #58.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.63B in Q2 2013. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 2,285,443 shares of Pfizer worth $64.2M as of Q1 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 93,526 Pfizer shares in Q1 2026, an estimated $2.49M.
  • Pfizer made up 0.16% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #58 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Pfizer position peaked at $1.63B in Q2 2013.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.